Literature DB >> 12047010

"Real world" atypical antipsychotic prescribing practices in public child and adolescent inpatient settings.

Elizabeth Pappadopulos1, Peter S Jensen, Sarah B Schur, James C MacIntyre, Scott Ketner, Kimberly Van Orden, Jeffrey Sverd, Sadhana Sardana, David Woodlock, Robert Schweitzer, David Rube.   

Abstract

This article examines the factors that influence antipsychotic use among youth treated in public inpatient facilities. By combining data from 11 focus groups, a survey of 43 researchers and clinicians, and a chart review of 100 closed patient charts, we investigated the interplay between physicians' and staff members' perceptions of problems related to antipsychotic prescribing, their beliefs concerning optimal approaches, their actual recorded prescribing behaviors, and the discrepancies between their beliefs and their recorded practices. We discovered that antipsychotics are prescribed broadly to treat a variety of conditions, including nonpsychotic disorders among children in public inpatient facilities. Despite overall expert consensus regarding "best practices," physicians described systemic obstacles that prevent the application of these practices, and our data confirmed that best practices are not always followed. Future research should be done with this patient population and should investigate the factors that influence antipsychotic use among inpatient youth.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12047010     DOI: 10.1093/oxfordjournals.schbul.a006913

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  16 in total

1.  Trends in psychotropic polypharmacy among youths enrolled in Ohio Medicaid, 2002-2008.

Authors:  Cynthia A Fontanella; Lynn A Warner; Gary S Phillips; Jeffrey A Bridge; John V Campo
Journal:  Psychiatr Serv       Date:  2014-10-31       Impact factor: 3.084

2.  The effects of prior authorization policies on medicaid-enrolled children's use of antipsychotic medications: evidence from two mid-Atlantic states.

Authors:  Bradley D Stein; Emily Leckman-Westin; Edward Okeke; Deborah M Scharf; Mark Sorbero; Qingxian Chen; Ka Ho Brian Chor; Molly Finnerty; Jennifer P Wisdom
Journal:  J Child Adolesc Psychopharmacol       Date:  2014-08-21       Impact factor: 2.576

3.  Predictors of polypharmacy and off-label prescribing of psychotropic medications: a national survey of child and adolescent psychiatrists.

Authors:  Marcia A Kearns; Kristin M Hawley
Journal:  J Psychiatr Pract       Date:  2014-11       Impact factor: 1.325

4.  Clinical Decision-Making in Community Children's Mental Health: Using Innovative Methods to Compare Clinicians With and Without Training in Evidence-Based Treatment.

Authors:  Mary J Baker-Ericzén; Melissa M Jenkins; Soojin Park; Ann F Garland
Journal:  Child Youth Care Forum       Date:  2015-02-01

Review 5.  Pharmacologic management of acutely agitated pediatric patients.

Authors:  Loretta Sonnier; Drew Barzman
Journal:  Paediatr Drugs       Date:  2011-02-01       Impact factor: 3.022

6.  Use of clozapine in a state child and adolescent psychiatric hospital.

Authors:  Vanessa Bobb; Michael Weinberg; Stewart Gabel; Harvey Kranzler; Mark Olfson
Journal:  Psychiatr Q       Date:  2013-09

7.  Antipsychotic polypharmacy in children and adolescents at discharge from psychiatric hospitalization.

Authors:  Shannon N Saldaña; Brooks R Keeshin; Anna M Wehry; Thomas J Blom; Michael T Sorter; Melissa P DelBello; Jeffrey R Strawn
Journal:  Pharmacotherapy       Date:  2014-07-03       Impact factor: 4.705

Review 8.  Prevalence and correlates of antipsychotic polypharmacy in children and adolescents receiving antipsychotic treatment.

Authors:  Nitin Toteja; Juan A Gallego; Ema Saito; Tobias Gerhard; Almut Winterstein; Mark Olfson; Christoph U Correll
Journal:  Int J Neuropsychopharmacol       Date:  2013-05-14       Impact factor: 5.176

9.  Psychotropic medications prescribing patterns for children and adolescents in New York's public mental health system.

Authors:  John S Lyons; James C MacIntyre; Michael E Lee; Sharon Carpinello; Michael P Zuber; Marcia L Fazio
Journal:  Community Ment Health J       Date:  2004-04

10.  Pharmacotherapy of aggression in children and adolescents: efficacy and effect size.

Authors:  Elizabeth Pappadopulos; Sophie Woolston; Alanna Chait; Matthew Perkins; Daniel F Connor; Peter S Jensen
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2006-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.